Sequencing for antimicrobial resistance surveillance
The Foundation for Innovative New Diagnostics (FIND) published a report on “Sequencing for antimicrobial resistance surveillance,” which highlights the importance of genomic sequencing in AMR surveillance; provides examples of next-generation sequencing technologies, workflows, and databases; and discusses the potential of culture-free sequencing.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.